WellCare downgraded to Sell from Neutral at Monness Crespi Monness Crespi downgraded WellCare based on Medicare Advantage rate pressures, and acquisition integration and execution risks. Price target is $55.
News For WCG From The Last 14 Days
Check below for free stories on WCG the last two weeks.
WellCare downgraded at Wedbush As noted earlier, Wedbush downgraded WellCare to Neutral from Outperform. The firm no longer sees the company as a takeover candidate, and it thinks that the company will need at least 2-3 years to turn itself around. Target to $55 from $70.